APFC American Pacific Corporation featured news, full reports, and detailed charts
American Pacific Corporation (APFC) Wrap Up:
We manufacture specialty and fine chemicals, as well as propulsion products sold to defense, aerospace and pharmaceutical end markets. Our products provide access to, and movement in, space via solid fuel and propulsion thrusters and represent the key active ingredient in drug applications such as HIV, epilepsy and cancer. We also produce specialty chemicals utilized in various applications such as agricultural and pesticide products and fire extinguishing systems, as well as manufacture water treatment equipment. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. Our technical and manufacturing expertise and customer service focus has gained us a reputation for quality, reliability, technical performance and innovation. Given the mission critical nature of our products, we maintain long standing strategic customer relationships. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f01%2f10%2f0000950153-07-000068.html#FIS_BUSINESS"American Pacific Corp. (APFC:NASDAQ)
Snapshot of American Pacific Corp. (APFC)
|
OPEN
$7.19
|
PREVIOUS CLOSE
$7.14
|
|
|
DAY HIGH
$7.45
|
DAY LOW
$7.13
|
|
|
52 WEEK HIGH
12/2/08 - $10.97
|
52 WEEK LOW
03/17/09 - $3.90
|
|
|
MARKET CAP
55.5M
|
AVERAGE VOLUME 3 mo
17.6K
|
|
|
DILUTED EPS TTM
$0.38
|
SHARES OUTSTANDING
7.5M
|
|
|
APFC Does Not Pay Dividends
|
P/E TTM
19.3x
|
|
| K = Thousands M = Millions B = Billions | ||
APFC Top Compensated Officers
Executives, Board Directors
Key developments for American Pacific Corp. (APFC)
American Pacific Corp. announced that John R. Gibson, Chairman of the Board of Directors and Chief Executive Officer, will retire as Chief Executive Officer, effective December 31, 2009, after leading the company for over 12 years. He will be succeeded as Chief Executive Officer by Dr. Joseph Carleone, who currently serves as President and Chief Operating Officer. Mr. Gibson will retain his role as Chairman of the Board of Directors. These changes are the result of succession planning begun by the Board of Directors several years ago and are intended to provide continuity in executing AMPAC's long-term strategic plans. Dr. Carleone's responsibility will be President and Chief Executive Officer. Mr. Gibson will continue to serve AMPAC as the non-executive Chairman of the Board of Directors.
American Pacific Corp. expected to Report Fiscal Year 2009 Results on December 7, 2009. This event was calculated by Capital IQ (Created on August 4, 2009).
American Pacific Corp. reported unaudited consolidated financial results for the third quarter and nine months ended June 30, 2009. For the quarter, revenues decreased $5.2 million, or 14%, to $31.5 million from $36.7 million for the same period of last year. Operating loss was $3.7 million compared to operating income of $2.4 million for the same period of last year. Adjusted EBITDA was $0.6 million compared to $6.6 million for the same period of last year. Net loss was $3.6 million compared to net income of $0.1 million for the same period of last year. Diluted and basic loss per share was $0.48 compared to diluted and basic earnings per share of $0.02 for the same period of last year. The company reported loss before income tax of $6.307 million compared to income before income tax of $266,000 for the same period of last year. For the nine months, revenues increased $1.6 million, or 1%, to $133.6 million from $132.0 million for the same period of last year. Operating income decreased to $6.0 million from $15.0 million for the same period of last year. Adjusted EBITDA decreased to $18.5 million from $28.7 million for the same period of last year. Net loss was $1.4 million compared to net income of $4.6 million for the same period of last year. Diluted and basic loss per share was $0.18 compared to diluted earnings per share of $0.61 for the same period of last year. The company reported loss before income tax of $1.992 million compared to income before income tax of $8.113 million for the same period of last year. The company reported net cash provided by operating activities of $11.352 million and capital expenditures of $6.312 million compared to net cash provided by operating activities of $21.141 million and capital expenditures of $10.027 million for the same period of last year. The company reaffirmed earnings guidance for the year of 2009. The company expects consolidated revenues for fiscal 2009 of at least $193.0 million and Adjusted EBITDA to range from $29 million to $32 million. The company anticipates capital expenditures for fiscal 2009 to be approximately $10.0 million. The low end of the range of fiscal 2009 guidance for Adjusted EBITDA is computed by adding estimated amounts for depreciation and amortization of $16.0 million, interest expense of $10.8 million, share-based compensation expense of $0.7 million and income taxes of $0.5 million to estimated net income of $1.0 million.
APFC Competitors
| Company | Last | Change |
| Gencorp Inc | $8.79 USD | +0.08 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | APFC | Industry Range |
| Price/Earnings | 18.8x |
|
| Price/Sales | 0.3x |
|
| Price/Book | 0.7x |
|
| Price/Cash Flow | 26.7x |
|
| TEV/Sales | NM | Not Meaningful |
|
APFC |
||
APFC transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
